Table 2.
Variables | Univariate | Multivariate | ||
---|---|---|---|---|
p Value | Hazard ratio | [95% CI] | p Value | |
(A) | ||||
Age | 0.127 | — | ||
Gender | 0.247 | — | ||
TNM score T1–T2 versus T3–T4 | 0.162 | — | ||
Positive lymph nodes | 0.815 | — | ||
Size ≥2 cm | 0.934 | — | ||
Differentiation | 0.715 | — | ||
Positive margin | 0.800 | — | ||
Lymphovascular invasion | 0.558 | — | ||
Perineural invasion | 0.826 | — | ||
Chronic pancreatitis | 0.115 | — | ||
Adjuvant chemotherapy | 0.952 | — | ||
High SFN plasmatic level | 0.308 | — | ||
(B) | ||||
Age | 0.161 | 0.955 | [0.90; 1.003] | 0.068 |
Gender | 0.421 | — | ||
TNM score T1–T2 versus T3–T4 | 0.593 | — | ||
Positive lymph nodes | 0.591 | — | ||
Size ≥2 cm | 0.659 | — | ||
Differentiation | 0.662 | — | ||
Positive margin | 0.865 | — | ||
Lymphovascular invasion | 0.105 | 1.94 | [0.83; 4.51] | 0.123 |
Perineural invasion | 0.790 | — | ||
Chronic pancreatitis | 0.508 | — | ||
Adjuvant chemotherapy | 0.369 | — | ||
High SFN plasmatic level | 0.019 | 2.380 | [1.02; 5.531] | 0.006 |
Bold values indicate statistical significance p < 0.05.